Cellromax Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	45,488	73,574	57,231
Market Cap Growth	-35.62%	28.56%	-
Enterprise Value	36,609	68,367	-
Last Close Price	4120.00	6361.12	4650.24
PE Ratio	13.64	24.80	14.99
PS Ratio	2.17	3.32	2.65
PB Ratio	0.96	1.57	1.29
P/TBV Ratio	1.01	1.67	1.39
P/FCF Ratio	22.17	43.11	9.40
P/OCF Ratio	21.36	41.21	9.09
EV/Sales Ratio	1.75	3.08	-
EV/EBITDA Ratio	13.04	20.63	-
EV/EBIT Ratio	15.71	24.11	-
EV/FCF Ratio	17.84	40.06	-
Debt / Equity Ratio	0.01	0.01	0.03
Debt / EBITDA Ratio	0.14	0.14	0.25
Debt / FCF Ratio	0.19	0.28	0.25
Net Debt / Equity Ratio	-0.19	-0.15	-0.48
Net Debt / EBITDA Ratio	-3.16	-2.18	-3.58
Net Debt / FCF Ratio	-4.33	-4.23	-3.49
Asset Turnover	0.42	0.44	-
Inventory Turnover	2.28	2.14	-
Quick Ratio	3.21	3.08	7.41
Current Ratio	4.87	5.20	9.10
Return on Equity (ROE)	7.58%	6.49%	-
Return on Assets (ROA)	2.89%	3.54%	-
Return on Invested Capital (ROIC)	5.94%	7.74%	17.55%
Return on Capital Employed (ROCE)	4.80%	5.90%	12.00%
Earnings Yield	7.51%	4.03%	6.67%
FCF Yield	4.51%	2.32%	10.64%
Payout Ratio	61.23%	114.25%	-
Buyback Yield / Dilution	-5.97%	-9.70%	-